Tumor necrosis factor-α and interleukin-10 contribute to immunoparalysis in patients with acute pancreatitis

Human Immunology

Volumn 72, Issue 1, 2011, Pages 18-23

  Ho, Yu Pin ^a   Chiu, Cheng Tang ^a   Sheen, I Shyan ^a   Tseng, Shu Chin ^a   Lai, Ping Chin ^a   Ho, Shin Yi ^a   Chen, Wei Ting ^a   Lin, Tsung Nan ^a   Lin, Chun Yen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Acute pancreatitis; HLA DR (human leukocyte antigen DR); Immunoparalysis; Interleukin 10; Tumor necrosis factor

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE RELEASE; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OUTCOME ASSESSMENT; PARALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; MONOCYTES; PANCREATITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650170076     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.10.002     Document Type: Article

References (25)

1. Neoptolemos J.P., Raraty M., Finch M., Sutton R. Acute pancreatitis: The substantial human and financial costs. Gut 1998, 42:886-891.
2. Johnson C.D., bu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004, 53:1340-1344.
3. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998, 42:S1-S13.
4. Uhl W., Warshaw A., Imrie C., Bassi C., McKay C.J., Lankisch P.G., et al. IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology 2002, 2:565-573.
5. McKay C.J., Evans S., Sinclair M., Carter C.R., Imrie C.W. High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg 1999, 86:1302-1305.
6. Buchler M.W., Gloor B., Muller C.A., Friess H., Seiler C.A., Uhl W. Acute necrotizing pancreatitis: Treatment strategy according to the status of infection. Ann Surg 2000, 232:619-626.
7. Howard T.J. As good as it gets: The study of prophylactic antibiotics in severe acute pancreatitis. Ann Surg 2007, 245:684-685.
8. Volk H.D., Thieme M., Heym S., Docke W.D., Ruppe U., Tausch W., et al. Alterations in function and phenotype of monocytes from patients with septic disease-predictive value and new therapeutic strategies. Behring. Instmitt 1991, 88:208-215.
9. Asadullah K., Woiciechowsky C., Docke W.D., Egerer K., Kox W.J., Vogel S., et al. Very low monocytic HLA-DR expression indicates high risk of infection-immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 1995, 2:184-190.
10. Docke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., et al. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 1997, 3:678-681.
11. Ho Y.P., Sheen I.S., Chiu C.T., Wu C.S., Lin C.Y. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 2006, 101:1117-1124.
12. Venet F., Tissot S., Debard A.L., Faudot C., Crampe C., Pachot A., et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med 2007, 35:1910-1917.
13. Lin C.Y., Tsai I.F., Ho Y.P., Huang C.T., Lin Y.C., Lin C.J., et al. Endotoxemia contributes to the immune paralysis in patients with liver cirrhosis. J Hepatol 2007, 46:816-826.
14. Monneret G., Lepape A., Voirin N., Bohe J., Venet F., Debard A.L., et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006, 32:1175-1183.
15. Bradley E.L. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993, 128:586-590.
16. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. Apache. II: A severity of disease classification system. Crit Care Med 1985, 13:818-829.
17. Ranson J.H., Rifkind K.M., Roses D.F., Fink S.D., Eng K., Spencer F.C. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974, 139:69-81.
18. Koppelman B., Neefjes J.J., de Vries J.E., de Waal M.R. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997, 7:861-871.
19. Wolk K., Docke W.D., von Baehr V., Volk H.D., Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96:218-223.
20. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996, 24:1125-1128.
21. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
22. Rau B.M. Outcome determinants in acute pancreatitis. Am J Surg 2007, 194(suppl 1):S39-S44.
23. Brivet F.G., Emilie D., Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: An early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999, 27:749-755.
24. West M.A., Heagy W. Endotoxin tolerance: A review. Crit Care Med 2002, 30(1 Suppl):S64-S73.
25. Malleo G., Mazzon E., Siriwardena A.K., Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: From biological basis to clinical evidence. Shock 2007, 28:130-140.